Wed, September 5, 2012
Tue, September 4, 2012
Mon, September 3, 2012
Sun, September 2, 2012
Sat, September 1, 2012
Fri, August 31, 2012
Thu, August 30, 2012
Wed, August 29, 2012
Tue, August 28, 2012
Mon, August 27, 2012
Sun, August 26, 2012
Sat, August 25, 2012
Fri, August 24, 2012
Thu, August 23, 2012
Wed, August 22, 2012
[ Wed, Aug 22nd 2012 ] - Market Wire
Inergetics Shareholder Update

AMAG Pharmaceuticals, Inc. to Participate in Upcoming Investor Conferences


//health-fitness.news-articles.net/content/2012/ .. articipate-in-upcoming-investor-conferences.html
Published in Health and Fitness on Wednesday, August 29th 2012 at 13:18 GMT by Market Wire   Print publication without navigation


LEXINGTON, Mass.--([ ])--AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG) today announced that William Heiden, AMAGas chief executive officer, will participate in two investor conferences in September. The sessions will both be conducted in a question and answer format and will include a company overview and a review of the companyas growth opportunities.

The sessions will take place as follows:

  • September 5, at 1:55 p.m. ET a" Bairdas 2012 Healthcare Conference in New York City; and
  • September 10, at 11:45 a.m. ET a" Morgan Stanley Global Healthcare Conference in New York City.

A live webcast of each session will be accessible through the Investor section of the companyas website at [ www.amagpharma.com ]. Following the conferences, the webcasts will be archived on the AMAG Pharmaceuticals, Inc. website for approximately two weeks.

About AMAG Pharmaceuticals, Inc.

AMAG Pharmaceuticals, Inc. is a specialty pharmaceutical company focused on the development and commercialization of a therapeutic iron compound to treat iron deficiency anemia. For additional company information, please visit [ www.amagpharma.com ].


Publication Contributing Sources